Welcome to the Gladden Longevity podcast, and in this episode, Dr. Gladden speaks with  Stephanie Venn Watson. Dr. Stephanie Venn-Watson, CEO of Seraphina Therapeutics, is a veterinary epidemiologist and public health scientist. With a background in Animal Physiology, Veterinary Medicine, and Public Health, she leads Seraphina, known for its research on pentadecanoic acid (C15:0). Fatty15, a C15:0 supplement, offers three times more cellular benefits than omega-3s, promoting long-term health. Users report improved metabolism, reduced anxiety, and better sleep within six weeks. This podcast emphasizes the critical role of C15:0, an essential fatty acid, in maintaining physiological health. She highlights a concerning population-wide crisis of C15:0 deficiency resulting from reduced-fat diets and the preference for plant-based milk alternatives devoid of C15:0. This deficiency, developed over 40 years, contributes to chronic diseases. C15:0, targeting key aging hallmarks, proves beneficial for metabolic, heart, liver, and immune health, as well as mood regulation and improved sleep.   Dr. Gladden notes that Stephanie is a fascinating person. (00:50) Dr. Gladden welcomed Stephanie to the show. (2:36) Stephanie talks about her previous work in combating different diseases. (4:45) Stephanie explains working with dolphins as a veterinarian. (6:57) What was it about dolphins that made them live longer with dementia? (9:44) Stephanie describes how measuring diet gave them a way to understand how diet affects the health of dolphins. (13:00) C15 was the number when measuring what was most import for dolphins. (15:20) C15 has been used for a long time. (17:53) Stephanie shares how C15 is an NPK activator. (19:57) C15 has potent anticancer activities, as identified in the lab. (22:20) Dr. Gladden asked if adding something else to C15 would make it work better. (24:40)   C15 meets all the criteria to be called an essential fatty acid. (26:05) They discovered that C15 repairs the mitochondrial function. (29:10) Dr. Gladden explains osmotic stressing as discussed. (32:18) Stephanie gives an example of a trial that was just conducted using C15. (35:50) Discovery that fatty liver disease is actually a C15 deficiency syndrome. (38:24) Dr. Gladden says the conversation is a fascinating conversation. (40:50) Stephanies looks forward to measuring the C15 effect on red blood cells. (45:19) C15 deficiency may be the reason for some kind of cell death. (48:30)   Use the code ‘podcast10’ to get 10% off your supplements at the Gladden Longevity Store   To know more about Stephanie: Websites: www.DiscoverC15.com  www.fatty15.com Instagram: (@fatty15) https://www.instagram.com/fatty15/   Affiliate Link/Code: http://www.fatty15.com/GLADDEN